Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study

PURPOSE: To determine the efficacy and safety of adalimumab (ADA) and etanercept (ETA) biosimilars in elderly and children with psoriasis. METHODS: A real-life retrospective observational study was conducted on pediatric (<18 years) and geriatric (≥65 years) psoriasis patients treated with anti-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Megna, Matteo, Fornaro, Luigi, Potestio, Luca, Luciano, Maria Antonietta, Nocerino, Mariateresa, Delfino, Mario, Guarino, Maria, Fabbrocini, Gabriella, Camela, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278721/
https://www.ncbi.nlm.nih.gov/pubmed/35844291
http://dx.doi.org/10.2147/PTT.S365493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278721/
https://www.ncbi.nlm.nih.gov/pubmed/35844291
http://dx.doi.org/10.2147/PTT.S365493

Ejemplares similares